Tag Archives: HQY

Top Blue Chip Stocks To Buy For 2019

I have been pleasantly surprised with the stock market. Incredible does not seem like strong enough of a word to describe the nearly decade-long bull market we’re in. 

Despite the roaring market, stocks never go up in a straight line. There are always pullbacks and sometimes severe plunges, even when everything looking super bullish. In fact, the worst plunges occur when investors are complacent and not expecting a selloff.

—Recommended Link— How The Confidential ‘MP Score’ Could Deliver 83% Gains In 28 Days
Beating the market 15 times over, our proprietary “MP Score” is the ONLY indicator that locates under-the-radar blue chips poised to take off. Read more here.

And if there ever were a time of investor complacency, it’s now. 

Today is the perfect time to review your portfolio to make certain it is protected against the downside. If the move higher is any indication, the move back down could be brutal.

Top Blue Chip Stocks To Buy For 2019: Bank of the Ozarks(OZRK)

Advisors’ Opinion:

  • [By Ethan Ryder]

    The Manufacturers Life Insurance Company lessened its stake in shares of Bank Of The Ozarks Inc (NASDAQ:OZRK) by 3.2% in the first quarter, HoldingsChannel.com reports. The firm owned 196,473 shares of the financial services provider’s stock after selling 6,499 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Bank Of The Ozarks were worth $9,484,000 at the end of the most recent quarter.

  • [By Motley Fool Staff]

    Bank of the Ozarks (NASDAQ: OZRK)Q2 2018 Bank Of The Ozarks Earnings CallJul. 12, 2018, 3:00 pm ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Stephen Mack]

    Bank of the Ozarks Inc. (Nasdaq: OZRK) began in 1903 with a community bank in Jasper, Ark. Now headquartered in Little Rock, the company operates more than 255 locations in the southeast, as well as in California, Texas, and New York.

  • [By Max Byerly]

    Bank of the Ozarks (NASDAQ:OZRK) has been assigned a consensus rating of “Hold” from the twelve ratings firms that are presently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, six have given a hold recommendation and five have assigned a buy recommendation to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $54.14.

  • [By Shane Hupp]

    Bank Of The Ozarks Inc (NASDAQ:OZRK) declared a quarterly dividend on Tuesday, July 3rd, Wall Street Journal reports. Investors of record on Friday, July 13th will be given a dividend of 0.20 per share by the financial services provider on Friday, July 20th. This represents a $0.80 annualized dividend and a yield of 1.76%. The ex-dividend date of this dividend is Thursday, July 12th. This is an increase from Bank Of The Ozarks’s previous quarterly dividend of $0.20.

Top Blue Chip Stocks To Buy For 2019: New York & Company Inc.(NWY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    News headlines about New York & Company, Inc. (NYSE:NWY) have trended somewhat positive this week, according to Accern. The research firm identifies negative and positive media coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. New York & Company, Inc. earned a news impact score of 0.09 on Accern’s scale. Accern also assigned media headlines about the specialty retailer an impact score of 46.8675047650936 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

  • [By Stephan Byrd]

    Strs Ohio bought a new stake in New York & Company, Inc. (NYSE:NWY) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 166,400 shares of the specialty retailer’s stock, valued at approximately $851,000. Strs Ohio owned approximately 0.26% of New York & Company, Inc. at the end of the most recent quarter.

  • [By Max Byerly]

    Cache (OTCMKTS: CACH) and New York & Company, Inc. (NYSE:NWY) are both small-cap retail/wholesale companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership.

  • [By Money Morning Staff Reports]

    After looking at this week’s penny stock gainers, we’ll give you that leg up with one of our top-rated penny stocks from our proprietary stock ranking system…

    Penny Stock Current Share Price (March 26) Last Week’s Gain
    Cartesian Inc. (OTCMKTS: CRTN) $0.39 170.69%
    Odyssey Marine Exploration Inc. (Nasdaq: OMEX) $8.76 135.90%
    iFresh Inc. (Nasdaq: IFMK) $8.25 64.64%
    China Auto Logistics Inc. (Nasdaq: CALI) $4.68 47.43%
    National American University Holdings Inc. (Nasdaq: NAUH) $1.20 39.29%
    Document Security Systems Inc. (NYSE: DSS) $1.58 33.91%
    Blonder Tongue Labs Inc. (NYSE: BDR) $0.77 33.90%
    CareDx Inc. (Nasdaq: CDNA) $7.49 29.88%
    Mediwound Ltd. (Nasdaq: MDWD) $5.10 26.51%
    New York & Co. Inc. (NYSE: NWY) $3.37 26.35%

    Don’t Miss This Shot at a $78,000 Windfall: This tiny firm is about to make the entire world wire-free. As its game-changing technology revolutionizes the global power structure, its stock could hand investors a massive return. Learn more…

  • [By Joseph Griffin]

    New York & Company, Inc. (NYSE:NWY) was upgraded by stock analysts at ValuEngine from a “hold” rating to a “buy” rating in a note issued to investors on Tuesday.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on New York & Company (NWY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Blue Chip Stocks To Buy For 2019: Western Asset Bond Fund(WEA)

Advisors’ Opinion:

  • [By Shane Hupp]

    Western Asset Premier Bond Fund (NYSE:WEA) hit a new 52-week high and low during mid-day trading on Thursday following a dividend announcement from the company. The stock traded as low as $12.63 and last traded at $12.63, with a volume of 12970 shares changing hands. The stock had previously closed at $12.63.

Top Blue Chip Stocks To Buy For 2019: Watts Water Technologies, Inc.(WTS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    These are some of the media headlines that may have effected Accern Sentiment’s scoring:

    Get tronc alerts:

    Edited Transcript of TRNC earnings conference call or presentation 9-Aug-18 9:00pm GMT (finance.yahoo.com) LA Times owner and biotech billionaire Patrick Soon-Shiong is in talks to join the group bidding for the newspaper company Tronc (businessinsider.com) LA Times owner and biotech billionaire Patrick Soon-Shiong is in talks to join the group bidding for newspaper company Tronc (msn.com) Analyst Target Price & Stock Review on Watts Water Technologies, Inc. (NYSE:WTS) and tronc, Inc. (NASDAQ:TRNC) (baycityobserver.com)

    Shares of TRNC traded up $0.20 during mid-day trading on Friday, reaching $16.47. 200,206 shares of the company’s stock traded hands, compared to its average volume of 316,188. The stock has a market cap of $582.27 million, a PE ratio of 15.25 and a beta of 1.78. The company has a current ratio of 1.16, a quick ratio of 1.13 and a debt-to-equity ratio of 0.02. tronc has a 12 month low of $13.00 and a 12 month high of $24.74.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Watts Water Technologies (WTS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    BNP Paribas Arbitrage SA lessened its stake in Watts Water Technologies Inc (NYSE:WTS) by 40.4% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 14,698 shares of the technology company’s stock after selling 9,975 shares during the quarter. BNP Paribas Arbitrage SA’s holdings in Watts Water Technologies were worth $1,142,000 as of its most recent SEC filing.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Watts Water Technologies (WTS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    First Trust Advisors LP lifted its position in Watts Water Technologies Inc (NYSE:WTS) by 20.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 157,253 shares of the technology company’s stock after acquiring an additional 26,663 shares during the period. First Trust Advisors LP’s holdings in Watts Water Technologies were worth $12,329,000 at the end of the most recent quarter.

  • [By Stephan Byrd]

    A number of institutional investors and hedge funds have recently made changes to their positions in WTS. SeaCrest Wealth Management LLC acquired a new position in Watts Water Technologies during the fourth quarter worth about $112,000. Xact Kapitalforvaltning AB acquired a new position in shares of Watts Water Technologies in the fourth quarter valued at approximately $224,000. Sawgrass Asset Management LLC acquired a new position in shares of Watts Water Technologies in the fourth quarter valued at approximately $270,000. Koch Industries Inc. raised its position in shares of Watts Water Technologies by 22.0% in the fourth quarter. Koch Industries Inc. now owns 3,821 shares of the technology company’s stock valued at $290,000 after buying an additional 690 shares during the last quarter. Finally, Quadrature Capital Ltd acquired a new position in shares of Watts Water Technologies in the fourth quarter valued at approximately $330,000. Institutional investors own 77.22% of the company’s stock.

    ILLEGAL ACTIVITY NOTICE: “Watts Water Technologies (WTS) Expected to Post Quarterly Sales of $362.52 Million” was originally posted by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another publication, it was illegally stolen and republished in violation of U.S. & international copyright & trademark law. The legal version of this piece of content can be accessed at www.tickerreport.com/banking-finance/3380368/watts-water-technologies-wts-expected-to-post-quarterly-sales-of-362-52-million.html.

    Watts Water Technologies Company Profile

Top Blue Chip Stocks To Buy For 2019: HealthEquity, Inc.(HQY)

Advisors’ Opinion:

  • [By Brian Feroldi]

    This backdrop has served as a fantastic tailwind for an innovative healthcare/tech company called HealthEquity (NASDAQ:HQY). The company provides employers, health plans, and individuals with tools and resources that enable them to maximize their savings and get the most out of every healthcare dollar. 

  • [By Brian Feroldi]

    In this week’s episode of Industry Focus: Healthcare, hidden-gems aficionado Brian Feroldi shares three exciting healthcare small caps that don’t stick investors with a mountain of risk — LeMaitre Vascular (NASDAQ:LMAT), HealthEquity (NASDAQ:HQY), and NovoCure (NASDAQ:NVCR). What do these companies do? How did they carve out a niche for themselves? What does the competition look like? And, because you can’t mitigate all the risk away, what risks should investors watch for? Tune in and find out more.

  • [By Max Byerly]

    Healthequity Inc (NASDAQ:HQY) – Research analysts at Barrington Research issued their Q2 2019 EPS estimates for shares of Healthequity in a report issued on Tuesday, June 5th. Barrington Research analyst A. Paris. Jr expects that the company will post earnings per share of $0.20 for the quarter. Barrington Research currently has a “Outperform” rating and a $85.00 target price on the stock. Barrington Research also issued estimates for Healthequity’s FY2019 earnings at $0.70 EPS.

  • [By Max Byerly]

    ValuEngine upgraded shares of HealthEquity (NASDAQ:HQY) from a buy rating to a strong-buy rating in a research report report published on Tuesday morning.

  • [By Max Byerly]

    CIBC Private Wealth Group LLC lessened its stake in Healthequity Inc (NASDAQ:HQY) by 2.2% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 175,651 shares of the company’s stock after selling 3,890 shares during the period. CIBC Private Wealth Group LLC owned about 0.28% of Healthequity worth $13,192,000 at the end of the most recent reporting period.

Hot Medical Stocks To Watch For 2019

&l;p&g;Most of us have had to try to confront some awkward issues with aging parents. It might be getting them to talk about the need for help at home. It could be about giving up those car keys. Hardest of all, perhaps, is the subject of end of life and advance healthcare planning. Estate planners have documents for that, but no one in healthcare is going to understand them unless families or loved ones are clear about the aging person&s;s wishes and can advocate for them.

&a;nbsp;

A document that empowers a decision maker to tell the medical providers what the elder wants are just vague enough to be capable of interpretation in several ways. For example, what is meant by &q;extraordinary measures&q; or &q;life prolonging treatment&q;, typical of words used in advance healthcare directives? Some will read them one way and others will see them differently. A talk with an aging parent can clear up vagueness but you need to know what to ask.

Not only have I had to bring up these topics with my own inlaws, I hear about a lot of friends who are in the same situation. Being Boomers, we may have aging parents still with us. If not, we are&q; the elders&q; ourselves and we need to have these discussions with our adult kids, friends or whomever we want to assign the task of being our own advocates. The good news is that we can get downloadable tools to help us.

Hot Medical Stocks To Watch For 2019: Eaton Vance Limited Duration Income Fund(EVV)

Advisors’ Opinion:

  • [By Logan Wallace]

    Eaton Vance Ltd Duration Income Fund (NYSEAMERICAN:EVV) was the recipient of a large increase in short interest in September. As of September 14th, there was short interest totalling 61,700 shares, an increase of 154.4% from the August 31st total of 24,249 shares. Currently, 0.1% of the company’s shares are short sold. Based on an average trading volume of 199,358 shares, the short-interest ratio is currently 0.3 days.

Hot Medical Stocks To Watch For 2019: Enova International, Inc.(ENVA)

Advisors’ Opinion:

  • [By Max Byerly]

    Enova International (NYSE: ENVA) and Regional Management (NYSE:RM) are both small-cap finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, earnings and institutional ownership.

  • [By Joseph Griffin]

    Enova International (NYSE:ENVA) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. According to Zacks, “Enova International, Inc. is a provider of online financial services. It offers loans to customers in the United States and in the United Kingdom, Australia and Canada. The Company’s customers include consumers who have bank accounts but use alternative financial credit services because of their limited access to more traditional consumer credit from banks, thrifts, credit card companies and other lenders. Enova International, Inc is headquartered in Chicago. “

  • [By Shane Hupp]

    Media stories about Enova International (NYSE:ENVA) have been trending somewhat positive recently, according to Accern. The research firm identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Enova International earned a news impact score of 0.17 on Accern’s scale. Accern also assigned news headlines about the credit services provider an impact score of 47.1141156093879 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Enova International (ENVA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Enova International (ENVA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8.
    Celyad SA (NASDAQ: CYAD) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica.
    DMC Global Inc. (NASDAQ: BOOM) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance.
    eHealth, Inc. (NASDAQ: EHTH) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results.
    Enova International, Inc. (NYSE: ENVA) climbed 20.4 percent to $27.20 following Q1 results.
    SVB Financial Group (NASDAQ: SIVB) shares jumped 18.2 percent to $304.135 following strong quarterly results.
    Knowles Corporation (NYSE: KN) gained 13.9 percent to $12.70 as the company reported Q1 results.
    Zymeworks Inc. (NYSE: ZYME) gained 13.8 percent to $17.36.
    Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday.
    ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial.
    Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 9.5 percent to $12.70.
    Expedia Group, Inc. (NASDAQ: EXPE) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday.
    Sprint Corporation (NYSE: S) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-M

Hot Medical Stocks To Watch For 2019: AdvanSix Inc. (ASIX)

Advisors’ Opinion:

  • [By Ethan Ryder]

    GSA Capital Partners LLP reduced its holdings in AdvanSix Inc (NYSE:ASIX) by 36.7% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 24,620 shares of the company’s stock after selling 14,277 shares during the quarter. GSA Capital Partners LLP owned about 0.08% of AdvanSix worth $856,000 as of its most recent filing with the SEC.

  • [By Max Byerly]

    AdvanSix (NYSE:ASIX) Director Michael Marberry bought 1,398 shares of the stock in a transaction on Monday, May 7th. The stock was purchased at an average price of $35.74 per share, for a total transaction of $49,964.52. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link.

  • [By Joseph Griffin]

    AdvanSix Inc (NYSE:ASIX) shares hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $32.23 and last traded at $32.33, with a volume of 2848 shares trading hands. The stock had previously closed at $32.70.

  • [By Logan Wallace]

    AdvanSix (NYSE:ASIX) was downgraded by stock analysts at ValuEngine from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Friday.

Hot Medical Stocks To Watch For 2019: NVIDIA Corporation(NVDA)

Advisors’ Opinion:

  • [By Beth McKenna]

    NVIDIA (NASDAQ:NVDA) reported powerful fiscal first-quarter 2019 results after the market close on Thursday. The graphics processing unit (GPU) specialist’s revenue jumped 66%, GAAP earnings per share soared 151%, and EPS adjusted for one-time factors rocketed 141%. Bottom-line results demolished Wall Street’s expectation, and the top line comfortably beat the consensus.

  • [By Beth McKenna]

    If so, here are four best-in-class stocks with solid long-term growth potential that are worth your consideration: graphics chip specialist NVIDIA (NASDAQ:NVDA), e-commerce and cloud-computing service behemoth Amazon.com (NASDAQ:AMZN), water utility giant American Water Works (NYSE:AWK), and water-technology specialist A.O. Smith (NYSE:AOS).  

  • [By Leo Sun]

    AMD likely forged that alliance with Intel to counter NVIDIA (NASDAQ:NVDA), which was aggressively expanding into notebooks with its M, MX, and GTX-series GPUs. However, Kaby Lake G’s arrival also confused many consumers, who erroneously thought it was an APU that merged an Intel CPU with an AMD GPU. That launch arguably overshadowed Ryzen Mobile’s arrival.

  • [By ]

    There are all sorts of different technologies to make it work and even different ways to get the same result. Even the companies involved are broad-based, ranging from big-tech like Alibaba Holding Group (BABA) to Intel Corporation (INTC)  , Alphabet Inc.  (GOOGL) (GOOG)  and Nvidia Corporation (NVDA)  — with Nvidia and Alphabet being holdings in Jim Cramer’s Action Alerts PLUS Charitable Trust Portfolio. There’s startups big and small, ride-sharing companies like Uber and Lyft, as well as seemingly every automaker getting involved.

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Magna International Inc. (NYSE: MGA) to report quarterly earnings at $1.7 per share on revenue of $10.11 billion before the opening bell. Magna shares gained 1.23 percent to $61.60 in after-hours trading.
    Analysts expect NVIDIA Corporation (NASDAQ: NVDA) to post quarterly earnings at $1.45 per share on revenue of $2.89 billion after the closing bell. NVIDIA shares rose 0.18 percent to $256.25 in after-hours trading.
    Synaptics, Incorporated (NASDAQ: SYNA) reported better-than-expected earnings for its third quarter, while sales missed estimates. Synaptics shares fell 7.43 percent to $43.00 in the after-hours trading session.
    After the markets close, News Corporation (NASDAQ: NWSA) is estimated to post quarterly earnings at $0.07 per share on revenue of $1.99 billion. News Corp shares gained 0.01 percent to $16.51 in after-hours trading.
    Analysts are expecting Duke Energy Corporation (NYSE: DUK) to have earned $1.14 per share on revenue of $5.78 billion in the latest quarter. Duke Energy will release earnings before the markets open. Duke Energy shares fell 0.03 percent to $77.62 in after-hours trading.
    Booking Holdings Inc (NASDAQ: BKNG) reported stronger-than-expected results for its first quarter. The company sees sales growth of 11.5-15.5 percent year over year and adjusted EBITDA in the range of $1.085 billion-$1.125 billion. Booking Holdings shares dropped 7.03 percent to $2,030.00 in the after-hours trading session.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Casey Wilson]

    The scientific community is absolutely ecstatic over this new technology.  In fact, this company just took home the highly prestigious Gold Edison Award – joining the likes of NVIDIA Corp. (Nasdaq: NVDA) and Tesla Inc. (Nasdaq: TSLA).

Hot Medical Stocks To Watch For 2019: CorVel Corp.(CRVL)

Advisors’ Opinion:

  • [By Ethan Ryder]

    CorVel Co. (NASDAQ:CRVL) Chairman V Gordon Clemons sold 2,250 shares of the company’s stock in a transaction on Thursday, June 21st. The stock was sold at an average price of $52.85, for a total transaction of $118,912.50. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

  • [By Max Byerly]

    GSA Capital Partners LLP grew its holdings in CorVel Co. (NASDAQ:CRVL) by 145.5% during the first quarter, HoldingsChannel reports. The firm owned 13,494 shares of the business services provider’s stock after acquiring an additional 7,997 shares during the period. GSA Capital Partners LLP’s holdings in CorVel were worth $682,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    AON (NYSE: AON) and CorVel (NASDAQ:CRVL) are both finance companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, profitability, risk, analyst recommendations and dividends.

Hot Medical Stocks To Watch For 2019: HealthEquity, Inc.(HQY)

Advisors’ Opinion:

  • [By Brian Feroldi]

    So where am I going to invest my capital? While I’m still refining my list, here are seven stocks that I currently own that I’m strongly considering adding to:

    Hubspot (NYSE: HUBS) — A software-as-a-service provider that is pioneering the shift toward “inbound” marketing. HealthEquity (NASDAQ: HQY) — A fast-growing company focused on Health Savings Accounts that boasts three sources of recurring revenue. Axon Enterprise (NASDAQ: AAXN) — The leading provider of Taser stun guns, law enforcement body cameras, and evidence-management software. Paycom Software (NYSE: PAYC) — A founder-led payroll-processor company that is gobbling up market share. Adobe Systems (NASDAQ: ADBE) — The company’s push to the cloud is driving double-digit gains in revenue and profits. AppFolio (NASDAQ: APPF) — A software-as-a-service provider focused on servicing business owners in several niche markets.  BlackLine (NASDAQ: BL) — A software company that is attempting to bring the accounting process into the 21st century. 

    All seven of these businesses are poised to deliver double-digit organic revenue and profit growth over the next five years. That’s a prospect I find quite enticing, and I think the odds are very favorable that they’ll outperform Apple as a group from here. 

  • [By Max Byerly]

    Here are some of the news headlines that may have impacted Accern’s analysis:

    Get Healthequity alerts:

    HealthEquity Inc. (HQY) VP Darcy G. Mott Cut 10000 Shares (bharatapress.com) Investors Love This Stock?: HealthEquity, Inc. (HQY) (bitcoinpriceupdate.review) Insider Selling: Healthequity Inc (HQY) Director Sells 15,000 Shares of Stock (americanbankingnews.com) Notable ETF Inflow Detected – IJT, STMP, HQY, TREX (nasdaq.com) You Need to Watch this stock? HealthEquity, Inc. (HQY) (connectinginvestor.com)

    Several brokerages have issued reports on HQY. Barrington Research boosted their price target on shares of Healthequity to $85.00 and gave the company an “outperform” rating in a report on Tuesday, June 5th. They noted that the move was a valuation call. Oppenheimer boosted their price target on shares of Healthequity from $68.00 to $85.00 and gave the company an “outperform” rating in a report on Tuesday, June 5th. Robert W. Baird boosted their price target on shares of Healthequity from $61.00 to $77.00 and gave the company a “neutral” rating in a report on Tuesday, June 5th. SunTrust Banks boosted their price target on shares of Healthequity from $70.00 to $85.00 and gave the company a “buy” rating in a report on Tuesday, June 5th. Finally, KeyCorp boosted their price target on shares of Healthequity from $72.00 to $82.00 and gave the company an “overweight” rating in a report on Tuesday, June 5th. Three investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $77.00.

  • [By Sean Williams, Chuck Saletta, and Brian Feroldi]

    With this in mind, we asked three Motley Fool investors to name one healthcare stock that’s tops on their list for the month of June. These three mid-cap stocks made the cut: royalty drug company Innoviva (NASDAQ:INVA), mental illness treatment center operator Acadia Healthcare (NASDAQ:ACHC), and health savings account provider HealthEquity (NASDAQ:HQY).

  • [By Max Byerly]

    Healthequity Inc (NASDAQ:HQY) – Research analysts at Barrington Research issued their Q2 2019 EPS estimates for shares of Healthequity in a report issued on Tuesday, June 5th. Barrington Research analyst A. Paris. Jr expects that the company will post earnings per share of $0.20 for the quarter. Barrington Research currently has a “Outperform” rating and a $85.00 target price on the stock. Barrington Research also issued estimates for Healthequity’s FY2019 earnings at $0.70 EPS.

  • [By Brian Feroldi]

    For example, I used finviz in the recent past to find a dynamic growth company called HealthEquity (NASDAQ:HQY). I quickly learned that HealthEquity’s revenue and earnings have compounded at 38% and 57%, respectively, over the last five years. Those numbers convinced me to dig deeper and I soon became so excited about the company’s prospects that I purchased shares for myself right away.

  • [By Brian Feroldi]

    This backdrop has served as a fantastic tailwind for an innovative healthcare/tech company called HealthEquity (NASDAQ:HQY). The company provides employers, health plans, and individuals with tools and resources that enable them to maximize their savings and get the most out of every healthcare dollar. 

Top 10 Medical Stocks To Invest In Right Now

Meet the Annuity Trust on Bernie Sanders Hit List

How to Get Medicaid for Nursing Home Care Without Going Broke

10 States Where the Millennials Are More Obese Than the Seniors

The $475,000 price tag on Novartis AG’s latest breakthrough cancer therapy came under fire from one of the biggest managers of drug costs in the United States, underscoring the challenges the Swiss drugmaker will face in promoting the potential blockbuster.

The cost of the leukemia treatment, called Kymriah, is “dramatically higher” than other such complex treatments, and the health care system isn’t ready to pay for it, Steve Miller, chief medical officer at Express Scripts Holding Co., said Thursday in a blog post on his company’s website. Gene therapies like Novartis’s are targeted at a small number of patients and typically used just once, meaning that drug companies have limited chances to recoup their investment.

“Therein lies the challenge,” Miller wrote. “We need a new payment model.”

Top 10 Medical Stocks To Invest In Right Now: Aqua America, Inc.(WTR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Connecticut Water Service (NASDAQ: CTWS) and Aqua America (NYSE:WTR) are both utilities companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, earnings and valuation.

  • [By ]

    Cramer was bearish on United States Steel (X) , Teva Pharmaceuticals (TEVA) , Aqua America (WTR) and Mueller Water Products (MWA) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Shane Hupp]

    Duff & Phelps Investment Management Co. reduced its stake in shares of Aqua America (NYSE:WTR) by 7.1% during the first quarter, Holdings Channel reports. The institutional investor owned 95,640 shares of the utilities provider’s stock after selling 7,290 shares during the quarter. Duff & Phelps Investment Management Co.’s holdings in Aqua America were worth $3,257,000 at the end of the most recent quarter.

  • [By Ethan Ryder]

    ValuEngine upgraded shares of Aqua America (NYSE:WTR) from a hold rating to a buy rating in a report released on Friday.

    Several other analysts also recently weighed in on the stock. Zacks Investment Research upgraded shares of Aqua America from a hold rating to a buy rating and set a $41.00 price objective on the stock in a research report on Monday, January 15th. Wells Fargo downgraded shares of Aqua America from an outperform rating to a market perform rating and dropped their price target for the stock from $43.00 to $37.00 in a research report on Monday, February 26th. UBS began coverage on shares of Aqua America in a research report on Thursday, March 8th. They set a neutral rating and a $36.00 price target on the stock. Finally, Boenning Scattergood restated a neutral rating on shares of Aqua America in a research report on Tuesday, April 24th. Seven equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The company presently has a consensus rating of Hold and a consensus target price of $38.29.

  • [By Joseph Griffin]

    Aqua America (NYSE: WTR) and SJW Group (NYSE:SJW) are both utilities companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, earnings, analyst recommendations, valuation and risk.

  • [By ]

    Aqua America (WTR) : “This is not the stock for a hot economy, even though this is a well-run company.”

    Mueller Water Products (MWA) : “This is not the time to buy. I don’t like the numbers.”

Top 10 Medical Stocks To Invest In Right Now: HealthEquity, Inc.(HQY)

Advisors’ Opinion:

  • [By Brian Feroldi]

    For example, I used finvizin the recent past to find a dynamic growth company called HealthEquity (NASDAQ:HQY). I quickly learned that HealthEquity’s revenue and earnings have compounded at 38% and 57%, respectively, over the last five years. Those numbers convinced me to dig deeper and I soon became so excited about the company’s prospects that I purchased shares for myself right away.

  • [By Max Byerly]

    Swiss National Bank grew its holdings in HealthEquity (NASDAQ:HQY) by 3.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 88,800 shares of the company’s stock after purchasing an additional 2,900 shares during the quarter. Swiss National Bank owned approximately 0.15% of HealthEquity worth $5,376,000 at the end of the most recent quarter.

  • [By Brian Feroldi]

    So where am I going to invest my capital? While I’m still refining my list, here are seven stocks that I currently own that I’m strongly considering adding to:

    Hubspot (NYSE: HUBS) — A software-as-a-service provider that is pioneering the shift toward “inbound” marketing. HealthEquity (NASDAQ: HQY) — A fast-growing company focused on Health Savings Accounts that boasts three sources of recurring revenue. Axon Enterprise (NASDAQ: AAXN) — The leading provider ofTaser stun guns, law enforcement body cameras, and evidence-management software. Paycom Software (NYSE: PAYC) — A founder-ledpayroll-processor company that is gobbling up market share. Adobe Systems (NASDAQ: ADBE)– The company’s push to the cloud is drivingdouble-digitgains in revenue and profits. AppFolio (NASDAQ: APPF) — Asoftware-as-a-service provider focused on servicing business owners in severalniche markets. BlackLine (NASDAQ: BL) — A software company that is attempting to bring the accounting process into the 21st century.

    All seven of these businesses are poised to deliver double-digit organic revenue and profit growth over the next five years. That’s a prospect I find quite enticing, and I think the odds are very favorable that they’ll outperform Apple as a group from here.

  • [By Max Byerly]

    ValuEngine upgraded shares of HealthEquity (NASDAQ:HQY) from a buy rating to a strong-buy rating in a research report report published on Tuesday morning.

  • [By Max Byerly]

    Healthequity Inc (NASDAQ:HQY) – Research analysts at Barrington Research issued their Q2 2019 EPS estimates for shares of Healthequity in a report issued on Tuesday, June 5th. Barrington Research analyst A. Paris. Jr expects that the company will post earnings per share of $0.20 for the quarter. Barrington Research currently has a “Outperform” rating and a $85.00 target price on the stock. Barrington Research also issued estimates for Healthequity’s FY2019 earnings at $0.70 EPS.

Top 10 Medical Stocks To Invest In Right Now: Genesis Energy, L.P.(GEL)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Stifel Financial Corp cut its stake in shares of Genesis Energy, L.P. common stock (NYSE:GEL) by 1.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 450,749 shares of the pipeline company’s stock after selling 7,788 shares during the quarter. Stifel Financial Corp owned about 0.37% of Genesis Energy, L.P. common stock worth $8,884,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Genesis Energy, L.P. common stock (GEL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Blair William & Co. IL cut its stake in Genesis Energy, L.P. common stock (NYSE:GEL) by 21.6% in the first quarter, HoldingsChannel.com reports. The fund owned 55,817 shares of the pipeline company’s stock after selling 15,409 shares during the period. Blair William & Co. IL’s holdings in Genesis Energy, L.P. common stock were worth $1,100,000 as of its most recent filing with the Securities and Exchange Commission.

Top 10 Medical Stocks To Invest In Right Now: Compass Diversified Holdings(CODI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Schroder Investment Management Group grew its stake in Compass Diversified Holdings (NYSE:CODI) by 3.2% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,097,576 shares of the financial services provider’s stock after purchasing an additional 33,776 shares during the period. Schroder Investment Management Group owned approximately 1.83% of Compass Diversified worth $18,000,000 at the end of the most recent reporting period.

Top 10 Medical Stocks To Invest In Right Now: Inogen, Inc(INGN)

Advisors’ Opinion:

  • [By Shane Hupp]

    Here are some of the news articles that may have impacted Accern Sentiment’s analysis:

    Get Inogen alerts:

    Comparing Halyard Health (HYH) and Inogen (INGN) (americanbankingnews.com) ‘The stock market has sucked on nitrous oxide’ Wall… (beaumontenterprise.com) EPS Calculations to Consider Inogen Inc (NASDAQ: INGN) (stocksmarketcap.com) Inogen’s shares drop on short seller Citron’s tweet (reuters.com) Inogen Hit By Citron Report; Analyst Rebuttal Calls This ‘An Excellent Entry Point’ (msn.com)

    Several equities analysts recently issued reports on the company. JPMorgan Chase & Co. raised their price target on Inogen from $150.00 to $180.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 1st. Leerink Swann restated an “outperform” rating and set a $170.00 price target (up from $150.00) on shares of Inogen in a research report on Tuesday, May 1st. ValuEngine upgraded Inogen from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, May 2nd. Zacks Investment Research upgraded Inogen from a “hold” rating to a “buy” rating and set a $131.00 price target on the stock in a research report on Tuesday, February 13th. Finally, BidaskClub upgraded Inogen from a “hold” rating to a “buy” rating in a research report on Friday, March 9th. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and three have issued a strong buy rating to the company. Inogen has an average rating of “Buy” and an average target price of $178.00.

  • [By Ethan Ryder]

    Inogen Inc (NASDAQ:INGN) Director Ray Benjamin M. Anderson sold 1,000 shares of the company’s stock in a transaction dated Monday, July 2nd. The stock was sold at an average price of $184.88, for a total value of $184,880.00. Following the completion of the transaction, the director now owns 1,989 shares in the company, valued at $367,726.32. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

  • [By Logan Wallace]

    Rock Springs Capital Management LP lifted its stake in shares of Inogen Inc (NASDAQ:INGN) by 38.1% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 110,500 shares of the medical technology company’s stock after purchasing an additional 30,500 shares during the quarter. Rock Springs Capital Management LP owned 0.52% of Inogen worth $13,574,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    Inogen Inc (NASDAQ:INGN) EVP Byron Myers sold 1,846 shares of the business’s stock in a transaction dated Monday, June 18th. The stock was sold at an average price of $190.04, for a total transaction of $350,813.84. Following the sale, the executive vice president now owns 39,121 shares in the company, valued at $7,434,554.84. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Top 10 Medical Stocks To Invest In Right Now: RELX N.V.(RENX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Relx (RENX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Invest In Right Now: American Financial Group, Inc.(AFG)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Media headlines about American Financial Group (NYSE:AFG) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies negative and positive news coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. American Financial Group earned a media sentiment score of 0.25 on Accern’s scale. Accern also assigned press coverage about the insurance provider an impact score of 46.840441381164 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

  • [By Joseph Griffin]

    Westpac Banking Corp increased its stake in shares of American Financial Group (NYSE:AFG) by 10.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 7,403 shares of the insurance provider’s stock after purchasing an additional 709 shares during the quarter. Westpac Banking Corp’s holdings in American Financial Group were worth $831,000 as of its most recent filing with the SEC.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on American Financial Group (AFG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Invest In Right Now: OneMain Holdings, Inc.(OMF)

Advisors’ Opinion:

  • [By Max Byerly]

    Rhumbline Advisers boosted its position in shares of OneMain Holdings Inc (NYSE:OMF) by 18.8% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 59,772 shares of the financial services provider’s stock after acquiring an additional 9,479 shares during the period. Rhumbline Advisers’ holdings in OneMain were worth $1,790,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Max Byerly]

    OneMain (NYSE: OMF) and Provident Financial (OTCMKTS:FPLPY) are both finance companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, profitability, analyst recommendations, valuation and risk.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on OneMain (OMF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Invest In Right Now: SPDR S&P Biotech ETF (XBI)

Advisors’ Opinion:

  • [By ]

    In a sea of red, small-cap biotech stocks stood strong during Wednesdays trading session. The SPDR S&P Biotech ETF (NYSE:XBI) finished the day higher by more than 1.25% while the Nasdaq Composite was stuck in the red. XBIs comeback rally that began to materialize just before Christmas is now threatening to break out to new highs.

  • [By Money Morning News Team]

    But the biotech sector crushed the market, with the SPDR S&P Biotech ETF (NYSE: XBI) returning a market-beating 43.36% in 2017, nearly double the broader S&P 500.

  • [By Jim Crumly]

    Technology was the weakest sector, with biotech and semiconductor stocks in particular having a tough day. TheSPDR S&P Biotech ETF (NYSEMKT:XBI) tumbled 3.2% and theiShares PHLX Semiconductor ETF (NASDAQ:SOXX) lost 2.4%.

  • [By ]

    More importantly, the SPDR S&P Biotech ETF (NYSE:XBI) has proven resilient during the volatility spike and selloff.

    In fact, XBI never closed significantly below its 50-day moving average as investors dumped stocks. That turned out to be a huge tell

Top 10 Medical Stocks To Invest In Right Now: Energy Fuels Inc(UUUU)

Advisors’ Opinion:

  • [By Logan Wallace]

    Old West Investment Management LLC purchased a new stake in Energy Fuels Inc (NYSEAMERICAN:UUUU) (TSE:EFR) in the first quarter, HoldingsChannel reports. The firm purchased 578,496 shares of the basic materials company’s stock, valued at approximately $1,003,000.

  • [By Stephan Byrd]

    Energy Fuels (NYSEAMERICAN:UUUU) (TSE:EFR) shares saw an uptick in trading volume on Monday . 1,091,365 shares were traded during mid-day trading, an increase of 300% from the previous session’s volume of 272,846 shares.The stock last traded at $2.09 and had previously closed at $2.04.

  • [By Stephan Byrd]

    Energy Fuels Inc (NYSEAMERICAN:UUUU) (TSE:EFR) was the recipient of a large increase in short interest during the month of June. As of June 15th, there was short interest totalling 2,265,513 shares, an increase of 19.6% from the May 31st total of 1,893,582 shares. Based on an average daily volume of 589,166 shares, the days-to-cover ratio is presently 3.8 days. Approximately 3.3% of the shares of the stock are short sold.

Top 5 Undervalued Stocks To Watch For 2019

Thor Industries (NYSE:THO) posted excellent results for FQ4 to cap off a strong year. Revenues increased 21.7%, beating estimates by a wide margin, and EPS of $1.57 came in ahead of estimates at $1.57. Net income from continuing operations increased 20.1% y/y. I have to admit I was surprised by the results. I expected that a weakening US economy would take its toll on the RV sector. In hindsight, of course, the performance makes sense. Consumers may be spending less on physical goods, but they are spending more on experiences such as travel and vacation, and low gas prices are still a tailwind. THO is up 53% YTD but we think the stock is, at a minimum, fairly valued, and quite possibly undervalued.

The Jayco acquisition, which closed on June 30, was partially responsible for the strong performance: Jayco sales contributed to 18% of the y/y increase in sales and 60% of the increase in consolidated RV backlog, which more than doubled y/y to $1.2 billion. Jayco provides a solid runway of growth going forward, and management expects sales to increase double digits in 2017. But THO also posted strong organic growth. Sales increased 14.4% y/y and Jayco contributed to less than a fifth of the increase. Conditions are close to ideal for the RV industry, and as long as gas prices and interest rates stay low (and we expect they will through 2017), THO should continue to post impressive y/y growth over the coming quarters.

Top 5 Undervalued Stocks To Watch For 2019: Yanzhou Coal Mining Company Limited(YZC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Thursday afternoon, energy shares slipped by just 0.1 percent. Meanwhile, top gainers in the sector included Superior Energy Services, Inc. (NYSE: SPN), and Yanzhou Coal Mining Co Ltd (ADR) (NYSE: YZC).

Top 5 Undervalued Stocks To Watch For 2019: Veeva Systems Inc.(VEEV)

Advisors’ Opinion:

  • [By Keith Speights, Brian Stoffel, and George Budwell]

    Healthcare is changing rapidly. Which companies will emerge as the huge winners with these major changes? We asked three of our healthcare contributors to weigh in on the subject. Here’s whyAbbVie (NYSE:ABBV),Alphabet (NASDAQ:GOOGL) (NASDAQ:GOOG), Johnson & Johnson (NYSE:JNJ), and Veeva Systems (NYSE:VEEV) could represent bold bets on the future of healthcare.

  • [By Brian Stoffel]

    Last week, management at Veeva Systems (NYSE:VEEV) reported earnings that investors have become accustomed to. In fact, shareholders have been downright spoiled: both the top and bottom lines came in ahead of expectations; annual sales growth from Veeva’s non-CRM division came in at a blistering 113%.

  • [By Jim Crumly]

    Cloud software vendor Veeva Systems (NYSE:VEEV) has had some extraordinary success selling its products to companies in the life sciences. It is now preparing to extend its reach into other industries, and long-term investors should be excited about the potential for the long runway of growth that could result.

  • [By Brian Stoffel]

    To say that Veeva Systems (NYSE:VEEV) has performed well as a publicly traded company would be an understatement. While the stock itself is actually down since its post-IPO days, the company’s fundamentals have vastly improved during that time frame.

  • [By Jim Robertson]

    Today, our Elite Opportunity Pronewsletter suggested mid cap global life sciencescloud-based software solutions stock Veeva Systems Inc (NYSE: VEEV) as a bullish long trade for investors who have patience:

Top 5 Undervalued Stocks To Watch For 2019: Clear Channel Outdoor Holdings, Inc.(CCO)

Advisors’ Opinion:

  • [By Sara Cornell]

    The agreement between the two companies allows Azincourt to option up to 70% of the East Preston property located in the Athabasca Basin. Home to Cameco’s (TSX:CCO) McArthur River uranium mine, the Athabasca Basin is considered one of the richest sources of uranium in the world, with many uranium deposits hosting grades substantially higher than the world average grade. The area has been a hotbed for energy metal investors over the past few years, due to significant high grade uranium discoveries by large cap mining companies.

Top 5 Undervalued Stocks To Watch For 2019: Trina Solar Limited(TSL)

Advisors’ Opinion:

  • [By Roberto Pedone]

    Another potential earnings short-squeeze candidate is integrated solar-power products maker Trina Solar (TSL), which is set to release numbers on next Monday before the market open. Wall Street analysts, on average, expect Trina Solar to report revenue of $645.68 million on earnings of 15 cents per share.

    The current short interest as a percentage of the float for Trina Solar is extremely high at 24.5%. That means that out of the 76.94 million shares in the tradable float, 18.88 million shares are sold short by the bears. If the bulls get the earnings news they’re looking for, then shares of TSL could easily rip sharply higher post-earnings as the bears move to cover some of their positions.

    From a technical perspective, TSL is currently trending below both its 50-day and 200-day moving averages, which is bearish. This stock recently formed a double bottom chart pattern at $8.67 to $9.04 a share. Shares of TSL have now started to rebound off those support levels and it’s quickly moving within range of triggering a major breakout trade post-earnings above some key near-term overhead resistance levels.

    If you’re bullish on TSL, then I would wait until after its report and look for long-biased trades if this stock manages to break out above some near-term overhead resistance levels at $10.72 to $11.19 a share and then above its 50-day moving average of $11.17 a share with high volume. Look for volume on that move that hits near or above its three-month average action of 5.17 million shares. If that breakout materializes post-earnings, then TSL will set up to re-test or possibly take out its next major overhead resistance levels at its 200-day moving average of $12.49 to $14 a share, or even $14.50 to $15 a share.

    I would avoid TSL or look for short-biased trades if after earnings it fails to trigger that breakout and then drops back below some near-term support levels at $10 a share to those double bottom support levels at $9.04 to $8

  • [By Elizabeth Balboa]

    The firm has a Sell rating on First Solar, JA Solar Holdings and Trina Solar Limited (ADR) (NYSE: TSL). It maintains a NC rating on SunPower Corporation, Canadian Solar and JinkoSolar Holding.

  • [By Spencer Israel]

    Axiom Capital Managing Director Gordon Johnson upgraded the entire alternative energy sector from Market Underweight to Market Overweight and upgraded SolarCity Corp (NASDAQ: SCTY) from Sell to Hold and Trina Solar Limited (ADR) (NYSE: TSL), Yingli Green Energy Holding Co Ltd (ADR) (NYSE: YGE) and JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO) from Sell to Buy.

Top 5 Undervalued Stocks To Watch For 2019: HealthEquity, Inc.(HQY)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider buying last week: Cidara Therapeutics Inc. (NASDAQ: CDTX), Ducommun Inc. (NYSE: DCO), HealthEquity Inc. (NASDAQ: HQY), Panhandle Oil and Gas Inc. (NYSE: PHX) and PolarityTE Inc. (NASDAQ: COOL).

Top 10 Stocks To Invest In 2018

Retirement Is Lifes Most Expensive Purchase

OMB Looks Ready to OK Delay of Fiduciary Rule

CFPB Barred, for Now, From Naming Company Under Investigation

As the nation anticipates President Donald Trump’s first budget, which will inevitably detail tax measures that will take a hit, new research by the Investment Company Institute finds that Americans value the current tax incentives for retirement saving and “overwhelmingly” oppose changing them.

ICI, a trade group for mutual funds and ETFs, reports that U.S. households favor preserving retirement account features and flexibility, with 89% of all US households disagreeing with the statement that the government should take away the tax advantages of defined contribution accounts, and 90% voting against the idea of reducing the amount that individuals can contribute to DC accounts.

You are signed up!

ThinkAdvisor’s TechCenter is an educational resource designed to give you a competitive edge by keeping you abreast of new tech innovations and need-to-know information that can be applied to your business. Resources STRAIGHT-THROUGH PROCESSING FOR THE FINANCIAL SERVICES INDUSTRY

STP can be described as electronically capturing and processing transactions in one pass, from the point of first ‘deal’ to final settlement.

Top 10 Stocks To Invest In 2018: Rice Midstream Partners LP(RMP)

Advisors’ Opinion:

  • [By Zacks]

    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
     
    Petroleo Brasileiro S.A.- Petrobras (NYSE: PBR): Free Stock Analysis Report
     
    Bill Barrett Corporation (NYSE: BBG): Free Stock Analysis Report
     
    Northern Oil and Gas, Inc. (AMEX:NOG): Free Stock Analysis Report
     
    Rice Midstream Partners LP (NYSE: RMP): Free Stock Analysis Report
     
    To read this article on Zacks.com click here.
     
    Zacks Investment Research

  • [By Paul Ausick]

    Rice Midstream Partners LP (NYSE: RMP) posted a new 52-week low of $16.87 on Monday, down about 31% compared with Friday’s closing price of $24.36. Volume totaled around 8.3 million shares, nearly 25 times the daily average of around 840,000. The company and its sponsor, Rice Energy, were acquired by EQT Corp.

Top 10 Stocks To Invest In 2018: SL Green Realty Corporation(SLG)

Advisors’ Opinion:

  • [By Nelson Hem]

    “Manhattan on Sale? That’s the Case With Two Cheap REITS” by Andrew Bary discusses whether Manhattan-focused real estate investment trusts Vornado Realty Trust (NYSE: VNO) and SL Green Realty Corp (NYSE: SLG) could rally as the New York market firms. Both trade at a discount to the value of private-market property deals, says the article.

Top 10 Stocks To Invest In 2018: athenahealth, Inc.(ATHN)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Athenahealth (ATHN) last night announced that its CFO and administrative chief, Kristi Matus, would be leaving the company. Her departure has not been embraced by investors, who have pushed shares lower today. Leerink’s David Larsen understands their concerns:

    In our view, the CFO departure may be indicative of internal operational challenges. We still think it is possible that Kristi Matus is seeking an environment that is not as demanding as ATHN, though this has not been confirmed by management. Management harped on the point that bifurcation is part of the strategic initiative of ATHN to reenergize the culture of the company, and Jonathan Bush noted how he himself hopes to spend more time on talent and culture and less time on entering new markets and building new products.

    We continue to believe that ATHN is facing challenges. We continue to believe the market is fundamentally slowing and bookings growth may become more lumpy as we progress through 2016. We still believe there will be a slow-down in the bookings growth rate b/c of a possible slow-down in the ambulatory EMR market and the fact that we are in the final payment year of Meaningful Use. Much of the call focused on Kristi Matus’s departure as a major loss for the company of a leader who was “masterful with investors.” According to management, the decision to split the CFO and CFAO responsibilities was not a reflection of her ability.

    Baird’s Matthew Gillmor and Sean McBride are less worried:

    The unexpected resignation of CFO Kristi Matus is disappointing, but the reasons for her departure seem somewhat understandable, in our view (potentially viewed bifurcation of CFO/CAO role as a demotion). We think incoming CFO Karl Stubelis is very strong and should provide helpful continuity, both internally and externally (currently serves as Controller and previously as acting CFO). Finally, the CFO change does not change our positive long-term thesi

  • [By WWW.THESTREET.COM]

    Shares of Athena Health (ATHN) are up 37% in just over a month. Is there still more room to run?

    Cramer said for years Athena had been a fast-growing stock, but as the company transitioned from growth to profitability, things began to get ugly. The company’s bombastic CEO, and his “colorful” personality began to rub shareholders the wrong way.

  • [By Dan Caplinger]

    Meanwhile, earnings season continued to play out, and although the technology industry saw some extremely encouraging reports, not all stocks participated in the rally. Athenahealth (NASDAQ:ATHN), Synchrony Financial (NYSE:SYF), and Time (NYSE:TIME) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By ]

    Under a single-payer system, healthcare becomes a regulated utility much like electricity with just a few large, best-in-class players. Athenahealth (Nasdaq: ATHN) could combine with Walgreen Boots Alliance (NYSE: WBA). Maybe each monolith will cover a specific region like Southern Company (NYSE: SO) and Consolidated Edison (NYSE: ED).

Top 10 Stocks To Invest In 2018: Golden Star Resources Ltd(GSS)

Advisors’ Opinion:

  • [By Cameron Saucier]

    Golden Star (NYSEMKT: GSS) is a gold mining and exploration company, and operates gold mines in Ghana, West Africa. GSS is up 396% YTD after it announced in July that it had begun pre-commercial production of gold in an underground mine in Ghana. GSS is trading at $0.825 per share on Monday intraday.

Top 10 Stocks To Invest In 2018: QLT Inc.(QLTI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Tuesday afternoon, healthcare shares gained by 0.61 percent. Meanwhile, top gainers in the sector included Kindred Healthcare, Inc. (NYSE: KND), and QLT Inc. (USA) (NASDAQ: QLTI).

Top 10 Stocks To Invest In 2018: ARMOUR Residential REIT, Inc.(ARR)

Advisors’ Opinion:

  • [By Amanda Alix]

    This development will likely give battered mREITs like Annaly Capital (NYSE: NLY  ) , Armour Residential (NYSE: ARR  ) , and American Capital Agency (NASDAQ: AGNC  ) a huge boost as investors begin to feel less panic regarding a tapering of the current QE3 program. Markets have responded to the Summers announcement by soaring skyward, apparently feeling relief and confidence about the fate of the taper.

  • [By Amanda Alix]

    It was just about one year ago that QE3 made its debut, and mortgage REITs, particularly agency-only players like Annaly Capital (NYSE: NLY  ) , Armour Residential (NYSE: ARR  ) , and American Capital Agency (NASDAQ: AGNC  ) began moaning about the increased competition for mortgage-backed securities guaranteed by Fannie Mae and Freddie Mac.

  • [By Lee Jackson]

    These companies also reported insider buying last week: Armour Residential REIT Inc. (NYSE: ARR), Ducommun Inc. (NYSE: DCO), PJT Partners Inc. (NYSE; PJT), Sonic Automotive Inc. (NYSE: SAH)and Tandy Leather Factory Inc. (NASDAQ: TLF).

Top 10 Stocks To Invest In 2018: L-3 Communications Holdings, Inc.(LLL)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows ViaSat, Inc plus mid to large cap communications stockslikeHarris Corporation (NYSE: HRS) and L-3 Communications Holdings, Inc (NYSE: LLL)had been moving in tandem until last yearwhile small cap Gogo Inc has underperformed:

  • [By Paul Ausick]

    Five teams are expected to compete for the contract: Boeing Co. (NYSE: BA) has joined with Saab to offer a clean-sheet design; Northrop Grumman Corp. (NYSE: NOC) has teamed up with BAE Systems and L-3 Communications Holdings Inc. (NYSE: LLL) on another clean-sheet design; Lockheed Martin Corp. (NYSE: LMT) and Korea Aerospace Industries (KAI) are going with a modified KAI T-50; Raytheon Corp. (NYSE: RTN) has joined with Italy’s Leonardo and Canada’s CAE Inc. (NYSE: CAE) on a version of Leonardo’s M-346 trainer that it calls the T-100; and privately held Sierra Nevada has partnered with Turkish Aerospace Industries (TAI) on another clean-sheet design.

  • [By Peter Graham]

    Headquartered in New York City, large cap L3 Technologies Inc (NYSE: LLL) employs approximately 38,000 people worldwide and is a leading provider of a broad range of communication, electronic and sensor systems used on military, homeland security and commercial platforms. L3 is also a prime contractor in aerospace systems, security and detection systems, and pilot training. The Company reported 2016 sales of $10.5 billion.

  • [By Chris Lange]

    L3 Technologies Inc. (NYSE: LLL) just hosted its investor day and projected that it wants to be considered among the top defense firms. Multiple analysts have raised their target prices. RBC raised its rating to Outperform from Sector Perform and its target price to $239 from $202. Other price target hikes were seen as follows: Cowen to $210 from $200, Jefferies to $201 from $188 and JPMorgan to $220 from $205.

Top 10 Stocks To Invest In 2018: The Blackstone Group L.P.(BX)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    At least if private-equity leviathan Blackstone Group LP (NYSE: BX) CEO Tony James has anything to say about it.

    You see, James has a working theory about what to do with the U.S. retirement system that currently charges participants large 401(k) and 403(b) asset and consulting percentage fees…

  • [By WWW.THESTREET.COM]

    Private equity giant Blackstone (BX) on Saturday announced that Saudi Arabia would invest $20 billion in a new $40 billion infrastructure fund for projects mainly in the United States. On Sunday, Boeing (BA) said it had signed several defense and commercial deals with Saudi Arabia. Trump was referenced in both deal announcements.

  • [By WWW.MONEYSHOW.COM]

    Of the ten PE companies that I follow, Blackstone Group LP (BX) is by far and away the largest publicly traded private equity partnership with a $35 billion market cap, but also the best positioned to benefit from all the catalysts noted within.

Top 10 Stocks To Invest In 2018: Alaska Air Group, Inc.(ALK)

Advisors’ Opinion:

  • [By Paul Ausick]

    The best airline, overall, was Alaska Air Group Inc. (NYSE: ALK). Other category winners were Spirit Airlines Co. (NASDAQ: SAVE), which was ranked cheapest; Alaska rated most reliable; JetBlue Airways Inc. (NASDAQ: JBLU) was most comfortable; best for pets was Alaska; and the airline receiving the fewest complaints was Southwest Airlines Co. (NYSE: LUV).

  • [By Ben Levisohn]

    Alaska Air Group (ALK) has advanced 1.3% to $94.55 after getting upgraded to Buy from Hold at Stifel.

    Shake Shack (SHAK) has risen 1.7% to $33 after getting upgraded to Neutral from Underperform at Wedbush.

  • [By Ben Levisohn]

    While the airline stocks have pulled back recently, coming off a choppy 1Q17, we have In-Line ratings on the Big 3 (American Airlines [AAL], Delta Air Lines [DAL] and United Continental [UAL]), as well as on Alaska Air Group (ALK)…

  • [By Adam Levine-Weinberg]

    It’s been clear from the beginning that Alaska Air’s (NYSE:ALK) acquisition of Virgin America was bad news for United Continental (NYSE:UAL). Alaska Air’s management viewed the deal as a springboard for growth in California — especially in the Bay Area. Meanwhile, United is the dominant airline in San Francisco.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Wednesday was Alaska Air Group, Inc. (NYSE: ALK) which rose over 4% to $64.43. The stocks 52-week range is $61.10 to $101.43. Volume was2.4 million compared to its average volume of 1.8 million.

Top 10 Stocks To Invest In 2018: HealthEquity, Inc.(HQY)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider buying last week: Cidara Therapeutics Inc. (NASDAQ: CDTX), Ducommun Inc. (NYSE: DCO), HealthEquity Inc. (NASDAQ: HQY), Panhandle Oil and Gas Inc. (NYSE: PHX) and PolarityTE Inc. (NASDAQ: COOL).